Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Clinical trial NCT00666991 · COMPLETED
Trial details
- NCT number
- NCT00666991
- Sponsor
- CritiTech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2013-05-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.